نتایج جستجو برای: lymphocyte associated antigen 4 ctla

تعداد نتایج: 2795929  

2012
Dorota Pastuszak-Lewandoska Ewa Sewerynek Daria Domańska Aleksandra Gładyś Renata Skrzypczak Ewa Brzeziańska

INTRODUCTION Autoimmune thyroid disease (AITD) is associated with both genetic and environmental factors which lead to the overactivity of immune system. Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) gene polymorphisms belong to the main genetic factors determining the susceptibility to AITD (Hashimoto's thyroiditis, HT and Graves' disease, GD) development. The aim of the study was to evaluate the ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Emily L Williams Stuart N Dunn Sonya James Peter W Johnson Mark S Cragg Martin J Glennie Juliet C Gray

PURPOSE Neuroblastoma is one of the commonest extracranial tumors of childhood. The majority of patients present with metastatic disease for which outcome remains poor. Immunotherapy is an attractive therapeutic approach for this disease, and a number of neuroblastoma tumor antigens have been identified. Here, we examine the therapeutic potential of combining immunomodulatory monoclonal antibod...

2012
Kuang Youlin Zhang Li Weng Xiaodong Liu Xiuheng Zhu Hengchen

Immune regulation has been shown to be involved in the progressive growth of some murine tumours. Interruption of immune regulatory pathways via activation of 4-1BB or cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blockade appears to be a promising strategy for cancer immunotherapy. In this study, we examined the effectiveness of 4-1BBL-expressing tumor cell vaccine in combination with C...

Journal: :International immunology 2005
Hiroshi Kataoka Shigekazu Takahashi Kan Takase Sho Yamasaki Tadashi Yokosuka Takao Koike Takashi Saito

Cytotoxic T lymphocyte antigen-4 (CTLA-4) is constitutively expressed on CD25(+)CD4(+) regulatory T cells (Treg) and is suggested to play a role in Treg-mediated suppression. However, the results of analysis with anti-CTLA-4 have been controversial. We addressed this issue by analyzing mice over-expressing or deficient in CTLA-4. For over-expression, CTLA-4 transgenic mice expressing a full-len...

Journal: :Journal of the American Society of Nephrology : JASN 1999
H Gudmundsdottir L A Turka

Optimal T cell responses occur when T cells receive both antigen-specific signals through the T cell receptor and non-antigen-specific costimulatory signals through accessory cell surface molecules. The best understood costimulatory receptor is CD28. Signals through the T cell receptor and CD28 cooperatively induce cytokine gene expression and promote T cell proliferation and survival. Negative...

Journal: :Annals of Oncology 2022

Immune checkpoint inhibitors (ICIs) targeting cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death 1 (PD-1) have improved overall survival (OS) in patients (pts) with advanced melanoma, neoadjuvant ICIs can induce tumor regression pts resectable melanoma. Targeting other co-inhibitory receptors, such as lymphocyte activation gene-3 (LAG-3) or immunoglobulin ITIM domain...

Journal: :Diabetes 2005
Andrea K Steck Teodorica L Bugawan Ana Maria Valdes Lisa M Emery Alan Blair Jill M Norris Maria J Redondo Sunanda R Babu Henry A Erlich George S Eisenbarth Marian J Rewers

Approximately 50% of the genetic risk for type 1 diabetes is attributable to the HLA region. We evaluated associations between candidate genes outside the HLA region-INS, cytotoxic T-lymphocyte-associated antigen (CTLA)-4, interleukin (IL)-4, IL-4R, and IL-13 and islet autoimmunity among children participating in the Diabetes Autoimmunity Study in the Young (DAISY). Children with persistent isl...

Journal: :The New England journal of medicine 2013
Chih-Chuan Yu Alessia Fornoni Astrid Weins Samy Hakroush Dony Maiguel Junichiro Sageshima Linda Chen Gaetano Ciancio Mohd Hafeez Faridi Daniel Behr Kirk N Campbell Jer-Ming Chang Hung-Chun Chen Jun Oh Christian Faul M Amin Arnaout Paolo Fiorina Vineet Gupta Anna Greka George W Burke Peter Mundel

Abatacept (cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion protein [CTLA-4-Ig]) is a costimulatory inhibitor that targets B7-1 (CD80). The present report describes five patients who had focal segmental glomerulosclerosis (FSGS) (four with recurrent FSGS after transplantation and one with primary FSGS) and proteinuria with B7-1 immunostaining of podocytes in kidney-biopsy speci...

Journal: :Blood 2005
Adriano Boasso Jean-Philippe Herbeuval Andrew W Hardy Christiana Winkler Gene M Shearer

Indoleamine-2,3-dioxygenase (IDO) and tryptophanyl-tRNA-synthetase (TTS) are interferon-gamma (IFN-gamma)-inducible enzymes that are responsible for tryptophan degradation and for its use in protein synthesis, respectively. IFN-gamma-induced IDO has immunomodulatory properties in murine and human models. A concomitant increase of TTS has been postulated to protect the IDO-expressing cells from ...

Journal: :The New England journal of medicine 2014
Timothy A Chan Jedd D Wolchok Alexandra Snyder

BACKGROUND Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs overall survival in patients with melanoma. CTLA-4 blockade activates T cells and enables them to destroy tumor cells. METHODS We obtaine...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید